Pathogenicity Islands PAPI-1 and PAPI-2 Contribute Individually and Synergistically to the Virulence of Pseudomonas aeruginosa Strain PA14

ABSTRACT Pseudomonas aeruginosa is a leading cause of hospital-acquired pneumonia and severe chronic lung infections in cystic fibrosis patients. The reference strains PA14 and PAO1 have been studied extensively, revealing that PA14 is more virulent than PAO1 in diverse infection models. Among other factors, this may be due to two pathogenicity islands, PAPI-1 and PAPI-2, both present in PA14 but not in PAO1. We compared the global contributions to virulence of PAPI-1 and PAPI-2, rather than that of individual island-borne genes, using murine models of acute pneumonia and bacteremia. Three isogenic island-minus mutants (PAPI-1-minus, PAPI-2-minus, and PAPI-1-minus, PAPI-2-minus mutants) were compared with the wild-type parent strain PA14 and with PAO1. Our results showed that both islands contributed significantly to the virulence of PA14 in acute pneumonia and bacteremia models. However, in contrast to the results for the bacteremia model, where each island was found to contribute individually, loss of the 108-kb PAPI-1 island alone was insufficient to measurably attenuate the mutant in the acute pneumonia model. Nevertheless, the double mutant was substantially more attenuated, and exhibited a lesser degree of virulence, than even PAO1 in the acute pneumonia model. In particular, its ability to disseminate from the lungs to the bloodstream was markedly inhibited. We conclude that both PAPI-1 and PAPI-2 contribute directly and synergistically in a major way to the virulence of PA14, and we suggest that analysis of island-minus strains may be a more appropriate way than individual gene knockouts to assess the contributions to virulence of large, horizontally acquired segments of DNA.

[1]  S. Musunuri,et al.  Pseudomonas aeruginosa Induces Localized Immunosuppression during Pneumonia , 2007, Infection and Immunity.

[2]  C. V. Rao,et al.  The Salmonella SPI1 Type Three Secretion System Responds to Periplasmic Disulfide Bond Status via the Flagellar Apparatus and the RcsCDB System , 2007, Journal of Bacteriology.

[3]  H. Schweizer,et al.  An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants , 2005, BMC Microbiology.

[4]  A. Hauser,et al.  Relative Contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to Virulence in the Lung , 2004, Infection and Immunity.

[5]  J. Rello,et al.  Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. , 2002, Critical care medicine.

[6]  S. Lynch,et al.  Presence or Absence of Lipopolysaccharide O Antigens Affects Type III Secretion by Pseudomonas aeruginosa , 2007, Journal of bacteriology.

[7]  J. Rello,et al.  Genomic islands of Pseudomonas aeruginosa. , 2009, FEMS microbiology letters.

[8]  E. Gulbins,et al.  Acid Sphingomyelinase Amplifies Redox Signaling in Pseudomonas aeruginosa-Induced Macrophage Apoptosis1 , 2008, The Journal of Immunology.

[9]  A. Prince,et al.  Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. , 2005, American journal of respiratory and critical care medicine.

[10]  B. Finlay,et al.  Salmonella and apoptosis: to live or let die? , 2001, Microbes and infection.

[11]  Roberto Kolter,et al.  Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis , 1998, Molecular microbiology.

[12]  Aras Kadioglu,et al.  Host Cellular Immune Response to Pneumococcal Lung Infection in Mice , 2000, Infection and Immunity.

[13]  S. Lory,et al.  Complete genome sequence of Pseudomonas aeruginosa PAO 1 , an opportunistic pathogen , 2000 .

[14]  Y. Michel-Briand,et al.  The pyocins of Pseudomonas aeruginosa. , 2002, Biochimie.

[15]  D. Hanahan.  Studies on transformation of Escherichia coli with plasmids. , 1983, Journal of molecular biology.

[16]  J. Goldberg,et al.  Regulation of lipopolysaccharide O antigen expression in Pseudomonas aeruginosa. , 2008, Future microbiology.

[17]  R. Robins-Browne,et al.  Contribution of FliC to Epithelial Cell Invasion by Enterohemorrhagic Escherichia coli O113:H21 , 2006, Infection and Immunity.

[18]  A. Ashkar,et al.  FimH Adhesin of Type 1 Fimbriae Is a Potent Inducer of Innate Antimicrobial Responses Which Requires TLR4 and Type 1 Interferon Signalling , 2008, PLoS pathogens.

[19]  Stephen Lory,et al.  Interstrain transfer of the large pathogenicity island (PAPI-1) of Pseudomonas aeruginosa , 2006, Proceedings of the National Academy of Sciences.

[20]  S. Lory,et al.  Acquisition and Evolution of the exoU Locus in Pseudomonas aeruginosa , 2006, Journal of bacteriology.

[21]  F. Ausubel,et al.  Differential Roles of the Pseudomonas aeruginosaPA14 rpoN Gene in Pathogenicity in Plants, Nematodes, Insects, and Mice , 2001, Journal of bacteriology.

[22]  B. Tümmler,et al.  In silico comparison of pKLC102-like genomic islands of Pseudomonas aeruginosa. , 2007, FEMS microbiology letters.

[23]  E. Giamarellos‐Bourboulis,et al.  Early apoptosis of blood monocytes is a determinant of survival in experimental sepsis by multi‐drug‐resistant Pseudomonas aeruginosa , 2007, Clinical and experimental immunology.

[24]  F. Ausubel,et al.  Use of the Galleria mellonella Caterpillar as a Model Host To Study the Role of the Type III Secretion System in Pseudomonas aeruginosa Pathogenesis , 2003, Infection and Immunity.

[25]  M. Hensel,et al.  Salmonella Pathogenicity Island 4-Mediated Adhesion Is Coregulated with Invasion Genes in Salmonella enterica , 2007, Infection and Immunity.

[26]  D. Ferguson,et al.  Novel Type IV Secretion System Involved in Propagation of Genomic Islands , 2006, Journal of bacteriology.

[27]  M. Rohde,et al.  Pseudomonas aeruginosa cupA‐encoded fimbriae expression is regulated by a GGDEF and EAL domain‐dependent modulation of the intracellular level of cyclic diguanylate , 2007 .

[28]  Qing Yang,et al.  Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Rohde,et al.  Pseudomonas aeruginosa cupA-encoded fimbriae expression is regulated by a GGDEF and EAL domain-dependent modulation of the intracellular level of cyclic diguanylate. , 2007, Environmental microbiology.

[30]  George A. O'Toole,et al.  In Vivo Growth of Pseudomonas aeruginosa Strains PAO1 and PA14 and the Hypervirulent Strain LESB58 in a Rat Model of Chronic Lung Infection , 2007, Journal of bacteriology.

[31]  Daniel G. Lee,et al.  The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Klockgether,et al.  Diversity of the Abundant pKLC102/PAGI-2 Family of Genomic Islands in Pseudomonas aeruginosa , 2006, Journal of bacteriology.

[33]  A. Kornberg,et al.  Inorganic polyphosphate is needed for swimming, swarming, and twitching motilities of Pseudomonas aeruginosa. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Pühler,et al.  A Broad Host Range Mobilization System for In Vivo Genetic Engineering: Transposon Mutagenesis in Gram Negative Bacteria , 1983, Bio/Technology.

[35]  J. Klockgether,et al.  Sequence Analysis of the Mobile Genome Island pKLC102 of Pseudomonas aeruginosa C , 2004, Journal of bacteriology.

[36]  Andy Gardner,et al.  Spite and virulence in the bacterium Pseudomonas aeruginosa , 2009, Proceedings of the National Academy of Sciences.

[37]  S. Lory,et al.  Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen , 2000, Nature.

[38]  L. Burrows,et al.  Genetics of O-Antigen Biosynthesis inPseudomonas aeruginosa , 1999, Microbiology and Molecular Biology Reviews.

[39]  B. Birren,et al.  Dynamics of Pseudomonas aeruginosa genome evolution , 2008, Proceedings of the National Academy of Sciences.

[40]  C. Sasakawa,et al.  Use of a novel approach, termed island probing, identifies the Shigella flexneri she pathogenicity island which encodes a homolog of the immunoglobulin A protease-like family of proteins , 1997, Infection and immunity.

[41]  D. Hume,et al.  Effector ExoU from the Type III Secretion System Is an Important Modulator of Gene Expression in Lung Epithelial Cells in Response to Pseudomonas aeruginosa Infection , 2003, Infection and Immunity.

[42]  H. Schweizer,et al.  Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa. , 1994, Gene.

[43]  S. Cross,et al.  Decreased Alveolar Macrophage Apoptosis Is Associated with Increased Pulmonary Inflammation in a Murine Model of Pneumococcal Pneumonia1 , 2006, The Journal of Immunology.

[44]  M. Hensel,et al.  Cooperation of Salmonella pathogenicity islands 1 and 4 is required to breach epithelial barriers , 2008, Cellular microbiology.

[45]  C. Roussos,et al.  Early apoptosis of blood monocytes in the septic host: is it a mechanism of protection in the event of septic shock? , 2006, Critical care.

[46]  J. Rello,et al.  Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. , 2003, The Journal of infectious diseases.

[47]  David J. Evans,et al.  Pseudomonas aeruginosa Invasion and Cytotoxicity Are Independent Events, Both of Which Involve Protein Tyrosine Kinase Activity , 1998, Infection and Immunity.

[48]  H. Schweizer,et al.  A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. , 1998, Gene.

[49]  Christian Weinel,et al.  Population structure of Pseudomonas aeruginosa , 2007, Proceedings of the National Academy of Sciences.

[50]  P. H. Griffiths,et al.  Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment , 1985, Veterinary Record.

[51]  B. Ryall,et al.  Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients , 2008, European Respiratory Journal.

[52]  J. Rello,et al.  Hybrid Pathogenicity Island PAGI-5 Contributes to the Highly Virulent Phenotype of a Pseudomonas aeruginosa Isolate in Mammals , 2008, Journal of bacteriology.

[53]  Frederick M. Ausubel,et al.  Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation , 2002, Nature.

[54]  L. Nicod,et al.  [Pseudomonas aeruginosa in chronic obstructive pulmonary disease]. , 2010, Revue medicale suisse.

[55]  A. Filloux,et al.  Expression of Pseudomonas aeruginosa CupD Fimbrial Genes Is Antagonistically Controlled by RcsB and the EAL-Containing PvrR Response Regulators , 2009, PloS one.

[56]  H. Vogel,et al.  Acetylornithinase of Escherichia coli: partial purification and some properties. , 1956, The Journal of biological chemistry.

[57]  C. Buchrieser,et al.  How to become a uropathogen: Comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains , 2006, Proceedings of the National Academy of Sciences.

[58]  G. Pier,et al.  Acquisition of Expression of the Pseudomonas aeruginosa ExoU Cytotoxin Leads to Increased Bacterial Virulence in a Murine Model of Acute Pneumonia and Systemic Spread , 2000, Infection and Immunity.

[59]  H. Schweizer.  Alielic exchange in Pseudomonas aeruginosa using novel ColE1‐type vectors and a family of cassettes containing a portable oriT and the counter‐selectable Bacillus subtilis sacB marker , 1992, Molecular microbiology.

[60]  D. Wareham,et al.  A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates. , 2007, International journal of medical microbiology : IJMM.

[61]  Kimberly A. Walker,et al.  Synchronous Gene Expression of the Yersinia enterocolitica Ysa Type III Secretion System and Its Effectors , 2009, Journal of bacteriology.

[62]  Vincent T. Lee,et al.  Activities of Pseudomonas aeruginosa Effectors Secreted by the Type III Secretion System In Vitro and during Infection , 2005, Infection and Immunity.

[63]  Li Li,et al.  Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial , 2006, Genome Biology.

[64]  Z. Dong,et al.  Role of EGFR transactivation in preventing apoptosis in Pseudomonas aeruginosa-infected human corneal epithelial cells. , 2004, Investigative ophthalmology & visual science.

[65]  S. Lynch,et al.  Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.

[66]  Frederick M. Ausubel,et al.  Identification of Virulence Genes in a Pathogenic Strain of Pseudomonas aeruginosa by Representational Difference Analysis , 2002, Journal of bacteriology.